DVA
52
-5
TGNA
50
-4
RIG
11
3
NRG
50
5
AAP
42
-2
SYY
52
2
GT
43
-2
AKAM
40
3
AEP
64
3
AVY
40
-3
RF
66
8
AZO
55
5
REGN
38
-2
PG
35
-2
NSC
68
4
PNC
61
2
VRSK
35
-3
AFL
48
3
ZBH
60
-5
DRI
57
12
DVA
52
-5
TGNA
50
-4
RIG
11
3
NRG
50
5
AAP
42
-2
SYY
52
2
GT
43
-2
AKAM
40
3
AEP
64
3
AVY
40
-3
RF
66
8
AZO
55
5
REGN
38
-2
PG
35
-2
NSC
68
4
PNC
61
2
VRSK
35
-3
AFL
48
3
ZBH
60
-5
DRI
57
12
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
60

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$33.19
Seasonality Move:
4.11%
Sell
32

SRPT
Sarepta Therapeutics

Last Price:
$14.08
Seasonality Move:
29.39%
Buy
60
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $33.18. The Score for ITDD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $14.08. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $33.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $14.08
    The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.2 Buy
Relative Strength Index (14 RSI): 64.34 Buy
Chaikin Money Flow: -7842 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.37 - 33.17) Buy
Bollinger Bands (100): (30.05 - 32.51) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.01 Buy
Relative Strength Index (14 RSI): 30.81 Sell
Chaikin Money Flow: -47284273 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.93 - 25.27) Sell
Bollinger Bands (100): (23.99 - 79.25) Sell

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.11 Buy
20-day SMA: 32.91 Buy
50-day SMA: 32.25 Buy
200-day SMA: 31.28 Buy
8-day EMA: 29.66 Buy
20-day EMA: 19.65 Buy
50-day EMA: 10.01 Buy
200-day EMA: 2.85 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.29 Sell
50-day SMA: 29.07 Sell
200-day SMA: 86.06 Sell
8-day EMA: 16.26 Sell
20-day EMA: 10.95 Buy
50-day EMA: 5.61 Buy
200-day EMA: 1.6 Buy

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $1.02 per share, a decrease this year of $6.30 per share, and an increase next year of $6.46 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):